We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$202M
AUM Growth
-$10.1M
(-4.7%)
Cap. Flow
+$30.2M
Cap. Flow
% of AUM
14.92%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
66
New
5
Increased
31
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$5.4M |
| 2 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$4.95M |
| 3 |
AtriCure
ATRC
|
+$3.16M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$2.95M |
| 5 |
Arrowhead Research
ARWR
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$7.83M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
+$3.38M |
| 3 |
Standard BioTools
LAB
|
+$2.38M |
| 4 |
Verastem
VSTM
|
+$1.72M |
| 5 |
ELGX
Endologix Inc
ELGX
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.41% |
| 2 | Energy | 3.37% |
| 3 | Miscellaneous | 2.41% |
| 4 | Real Estate | 2.4% |
| 5 | Financials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Viatris
VTRS
$19.1B
| $394K | 0.19% |
9,775
| – | – |
|
|
STJ
52
DELISTED
St Jude Medical
STJ
| $382K | 0.19% |
6,055
| – | – |
|
53
AstraZeneca
AZN
$251B
| $361K | 0.18% |
5,680
| – | – |
|
54
Johnson & Johnson
JNJ
$644B
| $357K | 0.18% |
3,820
| – | – |
|
55
Pfizer
PFE
$157B
| $330K | 0.16% |
11,088
| – | – |
|
56
Merck
MRK
$355B
| $326K | 0.16% |
6,927
| – | – |
|
57
Amgen
AMGN
$203B
| $322K | 0.16% |
2,330
| – | – |
|
58
Myriad Genetics
MYGN
$371M
| $293K | 0.14% |
7,820
| – | – |
|
59
Sanofi
SNY
$102B
| $270K | 0.13% |
5,680
| – | – |
|
60
Community Health Systems
CYH
$419M
| $263K | 0.13% |
7,435
| – | – |
|
|
STKL
61
DELISTED
SunOpta
STKL
| $244K | 0.12% |
50,230
-111,460
| -69% | -$1.01M |
|
62
Bio-Rad Laboratories Class A
BIO
$10.1B
| $225K | 0.11% |
1,675
| – | – |
|
63
Cytokinetics
CYTK
$9.64B
| – | – |
-218,792
| Closed | -$1.47M |
|
|
64
Standard BioTools
LAB
$271M
| – | – |
-98,209
| Closed | -$2.38M |
|
|
65
Verastem
VSTM
$665M
| – | – |
-19,045
| Closed | -$1.72M |
|
|
AMAG
66
DELISTED
AMAG Pharmaceuticals
AMAG
| – | – |
-113,368
| Closed | -$7.83M |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, First Light Asset Management held 66 positions worth $202M, down 4.7% from $212M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management deployed $30.2M of net new capital in Q3 2015, opening 5 new positions and adding to 31 existing holdings. Its largest new stake was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 95% a quarter earlier, followed by Energy and Miscellaneous.
On the sell side, the largest reduction was NxStage Medical Inc., an estimated $3.38M trimmed.
- First Light Asset Management's largest Q3 2015 buy was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
- First Light Asset Management added most to AtriCure in Q3 2015, an estimated $3.16M increase.
- First Light Asset Management's biggest Q3 2015 reduction was NxStage Medical Inc., cutting an estimated $3.38M.
- First Light Asset Management fully exited AMAG Pharmaceuticals in Q3 2015, selling an estimated $7.83M.
- First Light Asset Management's ten largest holdings make up 49% of its $202M portfolio in Q3 2015.
- First Light Asset Management opened 5 new positions and closed 4 in Q3 2015.
- First Light Asset Management's portfolio value fell 4.7% quarter-over-quarter to $202M.
Based on First Light Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.